Filter
2337
Filtered Results: 2337
Text search:
bacterial
infections
Featured
Recommendations
326
New Publications
591
Language
Document type
No document type
1063
Guidelines
460
Studies & Reports
379
Manuals
159
Fact sheets
85
Strategic & Response Plan
75
Training Material
58
Brochures
14
Situation Updates
13
Infographics
11
Videos
9
Online Courses
6
Resource Platforms
5
Countries / Regions
India
149
South Africa
71
Global
70
Kenya
57
Tanzania
42
Ethiopia
42
Nigeria
39
Nepal
35
Bangladesh
32
Africa
31
Sierra Leone
30
Western and Central Europe
30
Uganda
30
Latin America and the Carribbean
29
Rwanda
26
Philippines
26
Ghana
25
Namibia
23
Liberia
22
Malawi
20
Zambia
19
Myanmar / Burma
19
Germany
14
South–East Asia Region
12
Colombia
11
Venezuela
11
Argentina
11
Zimbabwe
10
Haiti
10
Paraguay
10
Eswatini/ Swaziland
10
Eastern Europe
9
Russia
9
Indonesia
9
Ukraine
8
Lesotho
8
Eastern Europe and Central Asia
8
Mozambique
7
Burkina Faso
6
Cambodia
6
Asia
6
West and Central Africa
6
Bolivia
6
Brazil
6
Madagascar
6
Senegal
5
USA
5
Western Pacific Region
5
Botswana
5
Cameroon
4
Syria
4
Peru
4
Congo, Democratic Republic of
4
East and Southern Africa
4
North Macedonia
3
Tajikistan
3
Timor Leste/ East Timor
3
China
3
Chile
3
Guinea
3
Middle East and North Africa
3
Spain
3
Vietnam
3
Angola
3
South Sudan
3
Iraq
3
Ecuador
3
Pakistan
3
Thailand
2
El Salvador
2
Serbia
2
Benin
2
Albania
2
Fiji
2
Afghanistan
2
Guinea-Bissau
2
Jordan
2
North America
2
Sri Lanka
2
Yemen
2
Honduras
2
Mali
2
Somalia
2
North Korea
1
Mexico
1
Gambia
1
Kazakhstan
1
Iran
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Qatar
1
Armenia
1
Saudi Arabia
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Latvia
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Egypt
1
Sudan
1
Georgia
1
Central African Republic
1
Libya
1
Bhutan
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
781
Clinical Guidelines
310
Key Resources
144
Women & Child Health
139
Public Health
88
Capacity Building
58
Pharmacy & Technologies
40
Toolboxes
AMR
351
TB
210
COVID-19
149
HIV
142
NTDs
132
Rapid Response
116
Planetary Health
90
Caregiver
81
Pharmacy
68
Cholera
45
Ebola & Marburg
44
Refugee
40
Mental Health
34
Conflict
24
Natural Hazards
23
NCDs
23
Malaria
21
Global Health Education
19
Specific Hazards
14
Disability
14
Zika
12
Polio
8
Health Financing Toolbox
3
Social Ethics
1
To improve survival and quality of life among the 2.5 million children living with HIV, a comprehensive package of prevention, care and treatment is required. This package should include management of infections such as pneumonia, diarrhoea, malaria and ear infections, as well as common opportunisti...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial ...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Outline
• Welcome and objectives
• Microbiology, epidemiology and clinical presentation
• Surveillance for imported cases including case definitions
• Laboratory diagnosis • Infection prevention and hospital readiness
• Patient flow and actions required at each step
• Co-ord...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist...
The National Strategic Plan for HIV/AIDS and STIs 2017-2024 spells out the objectives and targets that we have jointly committed to achieve. The plan describes the strategies and activities that will need to be implemented on the ground across India's 36 States and Union Territories with the help of...
This purpose of this guide is to inform robust evaluations of the WHO training package – a package aimed at personnel whose primary role in health-care facilities is environmental cleaning, hereafter referred to as cleaners.
The WHO training package – Environmental cleaning and infection prev...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Antimicrobial resistance (AMR) as a serious public health threat was globally acknowledged by WHO in 2015, through the launch of the Global Action Plan (GAP). With a limited number of new antibiotics in the developmental pipeline, many countries are in the process of establishing strategies for anti...
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3026 (Published 11 August 2020)
The BMJ "practice pointer" inlcudes a one-page visual summary of assessment and initial management of patients with persistant symptoms following acute SARS-CoV-2 infection
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Most of the global burden of sepsis occurs in low- and middle-income countries (LMICs), but the prevalence and etiology of sepsis in LMICs are not well understood. In particular, the lack of laboratory infrastructure in many LMICs has historically precluded an assessment of the pathogens leading to ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
This publication provides recommendations for the management of critically ill adult patients with COVID-19 being treated in intensive care units (ICUs) in the Americas. These clinical practice guidelines provide evidence-informed recommendations for identifying markers and mortality risk factors in...
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West...
Ce document fournit des orientations provisoires sur la qualité, les caractéristiques de performance et les normes connexes des équipements de protection individuelle (EPI) à utiliser dans le contexte de COVID-19. Il s'agit notamment des dispositifs médicaux prioritaires de l'OMS, à savoir : l...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen...
